Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Convertible Debt (2018 - 2024)

Bioadaptives' Convertible Debt history spans 7 years, with the latest figure at $461000.0 for Q4 2024.

  • On a quarterly basis, Convertible Debt changed N/A to $461000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $461000.0, a N/A change, with the full-year FY2024 number at $461000.0, changed N/A from a year prior.
  • Convertible Debt hit $461000.0 in Q4 2024 for Bioadaptives, up from $311000.0 in the prior quarter.
  • Over the last five years, Convertible Debt for BDPT hit a ceiling of $479284.0 in Q2 2021 and a floor of $311000.0 in Q2 2024.
  • Historically, Convertible Debt has averaged $383833.9 across 5 years, with a median of $388967.0 in 2020.
  • Biggest five-year swings in Convertible Debt: soared 112.63% in 2020 and later fell 28.24% in 2023.
  • Tracing BDPT's Convertible Debt over 5 years: stood at $405236.0 in 2020, then fell by 0.52% to $403117.0 in 2021, then dropped by 5.29% to $381793.0 in 2022, then dropped by 14.7% to $325671.0 in 2023, then surged by 41.55% to $461000.0 in 2024.
  • Business Quant data shows Convertible Debt for BDPT at $461000.0 in Q4 2024, $311000.0 in Q3 2024, and $311000.0 in Q2 2024.